Galli, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.726
AS - Asia 2.239
EU - Europa 1.368
SA - Sud America 373
AF - Africa 44
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.661
SG - Singapore 713
CN - Cina 604
IT - Italia 549
BR - Brasile 285
HK - Hong Kong 275
VN - Vietnam 261
GB - Regno Unito 167
SE - Svezia 122
FI - Finlandia 104
BD - Bangladesh 101
RU - Federazione Russa 97
KR - Corea 84
DE - Germania 81
FR - Francia 65
NL - Olanda 40
ID - Indonesia 39
AR - Argentina 37
AT - Austria 27
CA - Canada 26
JP - Giappone 25
MX - Messico 25
IN - India 23
IQ - Iraq 20
TR - Turchia 20
BG - Bulgaria 19
PL - Polonia 18
AU - Australia 17
MA - Marocco 17
EC - Ecuador 14
LT - Lituania 12
PK - Pakistan 12
CL - Cile 11
AE - Emirati Arabi Uniti 10
ES - Italia 10
ZA - Sudafrica 9
IE - Irlanda 8
PT - Portogallo 8
CO - Colombia 7
TW - Taiwan 7
EG - Egitto 6
HU - Ungheria 6
KG - Kirghizistan 6
PE - Perù 6
UA - Ucraina 6
VE - Venezuela 6
IL - Israele 5
KE - Kenya 5
MY - Malesia 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
GR - Grecia 4
BE - Belgio 3
CR - Costa Rica 3
GT - Guatemala 3
IR - Iran 3
PH - Filippine 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JM - Giamaica 2
JO - Giordania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.767
Salva come PNG Salva come JPEG
Città #
Santa Clara 494
Singapore 415
Ashburn 314
Hong Kong 272
Hefei 238
San Jose 217
Chandler 150
Fairfield 145
Ho Chi Minh City 98
London 93
Helsinki 92
Beijing 87
Nyköping 82
Seoul 82
Council Bluffs 74
Milan 67
New York 64
Los Angeles 61
Moscow 49
Dallas 48
Hanoi 46
Seattle 45
The Dalles 44
Wilmington 44
Cambridge 41
Bologna 38
Chicago 38
Woodbridge 37
Houston 36
Buffalo 35
Shanghai 28
Jakarta 27
Rome 27
Lauterbourg 26
Princeton 23
São Paulo 23
Modena 22
San Diego 22
Munich 21
Salt Lake City 21
Nuremberg 18
Florence 17
Sofia 17
Ann Arbor 16
Atlanta 15
Kent 15
Tokyo 15
Da Nang 14
Southend 14
Haiphong 13
Rio de Janeiro 13
Boardman 12
Naples 12
Orem 12
Redondo Beach 12
Reggio Emilia 12
Brooklyn 11
Parma 11
Ankara 10
Columbus 10
Louisville 10
Portsmouth 10
Vienna 10
Biên Hòa 9
Elk Grove Village 9
Frankfurt am Main 9
Melbourne 9
Mexico City 9
Bremen 8
Casablanca 8
Des Moines 8
Ksawerów 8
Lappeenranta 8
Porto Alegre 8
Warsaw 8
Bari 7
Brasília 7
Dearborn 7
Dublin 7
Padova 7
Amsterdam 6
Cagliari 6
Chennai 6
Dhaka 6
Lahore 6
Montreal 6
Palermo 6
Paris 6
Quito 6
Santiago 6
Shijiazhuang 6
Tampa 6
Thái Bình 6
Toronto 6
Treviso 6
Trieste 6
Baghdad 5
Bergamo 5
Bishkek 5
Caivano 5
Totale 4.337
Salva come PNG Salva come JPEG
Nome #
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 341
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 333
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 285
EULAR guidelines on ANCA-associated vasculitis in the real life 269
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 246
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 230
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 229
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 220
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 208
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 197
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 189
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 184
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 183
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 182
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: Multicenter retrospective study of 209 patients 179
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 177
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study 171
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy 169
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 160
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 160
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? 154
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 154
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 152
Development of the Takayasu Arteritis Integrated Disease Activity Index 152
What to Know About Biopsy Sampling and Pathology in Vasculitis? 149
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study 143
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 141
The management of large vessel vasculitides 140
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 135
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 134
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 133
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 132
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 127
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 123
Response to: COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: A cross-sectional patient survey study' by Cuceoglu et al 120
Response to ‘The Relevance of Restricted Inflammation in a TAB’ by Griffin KJ et al 120
Current management of giant cell arteritis and its complications 116
Reply 113
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 76
Totale 6.826
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/2022435 34 18 44 18 14 26 23 24 38 28 98 70
2022/2023590 54 64 33 35 71 76 31 66 82 17 32 29
2023/2024493 12 30 14 58 47 49 59 78 20 33 42 51
2024/20251.740 33 20 23 119 350 293 162 62 177 113 192 196
2025/20263.312 264 188 295 401 357 203 388 172 371 238 251 184
Totale 6.826